易秉明博士目前就任葛兰素史克（上海）中国研发有限公司统计，流行病学，和数据管理部门总监。他毕业于北京大学，获得学士和硕士学位，后来又获得美国北卡罗莱纳州立大学统计学博士学位。
易博士在国际制药行业工作十三年，拥有丰富的经验，包括非临床，动物试验和人体临床方面的产品研究和发展，工作领域涉及很多不同种类的适应症。他曾经在美国默沙东工作过三年半，其中他参与研发的一个糖尿病产品（Januvia）成功上市，2012年销售额达40亿美元，目前也已经在中国市场销售（捷诺维）。
易博士在葛兰素史克工作共九年多时间。2011年初，他从美国公司回到上海，组建了一支富有经验的统计，流行病学，和数据管理团队。团队成员平均拥有五年多的工作经验，其中一半为从美国回来的海归。
Bingming Yi is currently the head of Statistics, Epidemiology, and Data Management in GSK R&D China (Shanghai). He graduated from Peking University, with Bachelor and Master Degree, and holds Ph.D. Degree in Statistics in North Carolina State University in USA.
Bingming has total of 13 years of experience working in pharmaceutical industry, including preclinical and clinical research in drug discovery and development, in various therapeutic areas. He worked for Merck and Co. in USA for 3.5 years. One compound he worked on, now named Januvia, became a block buster for diabetes and had been successfully put in Chinese market.
Bingming has worked for GSK for more than 9 years, most in GSK US. Since early 2011, he came back to Shanghai, and has built up a strong team of statistical, data management, and Epi for R&D China. The team has an average of 5 years of experience, and half came from US as Sea Turtles.
The research areas Bingming is interested in include Bayesian Statistics and adaptive designs.